Seeking Alpha

Acadia Pharmaceuticals (ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K. (PR)

Acadia Pharmaceuticals (ACAD): Q4 EPS of ($0.10) in line. Revenue of $588K beats by $38K. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)